Who is moving to which position
Resolved 17 September 2026Incoming appointee
1 itemDeparting officer
1 item“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.
Continuing in office as Director
The Company determined that, because operating losses in its existing businesses have continued and its growth strategy in the healthcare sector has been forced into a significant stagnation, it would be difficult to rebuild the growth strategy and restore the existing businesses under the current management structure.
Because, after working as a physician in clinical medicine, he established and managed a medical corporation himself, and has specialised knowledge of the healthcare sector and management experience.
| Item | Details |
|---|---|
| Resolution date | 17 September 2026 |
| Scheduled Appointment Date | 17 September 2026 (today) |
| Date of departure | 17 September 2026 |
| Name of appointee | Saka Tatsunori (坂達典) |
| Appointee's new position | Representative Director and President |
| Appointee's previous position | Directors |
| Appointee's date of birth | 29 December 1990 |
| Year the appointee joined the Company | 2026 |
| Number of shares held by the appointee | 0 shares (record date not stated) |
| Name of departing officer | Matsukawa Hiroshi (松川裕史) |
| Former position of departing officer | Representative Director and President |
| New position of departing officer | Directors |
| Whether the incumbent will remain in office | Continuing in office as Director |
| Reason for change | The Company determined that, because operating losses in its existing businesses have continued and its growth strategy in the healthcare sector has been forced into a significant stagnation, it would be difficult to rebuild the growth strategy and restore the existing businesses under the current management structure. |
| Reasons for appointment | Because, after working as a physician in clinical medicine, he established and managed a medical corporation himself, and has specialised knowledge of the healthcare sector and management experience. |
Items this document does not state (6)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company states that, as operating losses in its existing businesses have continued and its growth strategy in the healthcare sector has suffered a significant setback, it will refresh its management structure and pursue business restructuring and the recovery of its existing businesses under Saka Tatsunori (坂達典), who has medical and management expertise.